Cargando…
Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
Ongoing efforts to improve clinical trial design in irritable bowel syndrome have been hindered by high placebo response rates and ineffective outcome measures. We assessed established strategies to minimize placebo effect as well as the various approaches to placebo effect which can affect trial de...
Autores principales: | Shah, Eric, Pimentel, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015207/ https://www.ncbi.nlm.nih.gov/pubmed/24840369 http://dx.doi.org/10.5056/jnm.2014.20.2.163 |
Ejemplares similares
-
Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017) -
Study design considerations for irritable bowel syndrome clinical trials
por: Miller, Larry E.
Publicado: (2014) -
Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022) -
Estimating the Contribution of Acute Gastroenteritis to the Overall Prevalence of Irritable Bowel Syndrome
por: Shah, Eric D, et al.
Publicado: (2012) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)